Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV
- PMID: 8380463
- PMCID: PMC237424
- DOI: 10.1128/JVI.67.2.726-733.1993
Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV
Abstract
Glycoprotein gIV, a structural component of bovine herpesvirus type 1, stimulates high titers of virus-neutralizing antibody. The protein contains three potential sites for the addition of N-linked carbohydrates. Three mutants were constructed by oligonucleotide-directed mutagenesis, in each case changing one N-linked glycosylation site from Asn-X-Thr/Ser to Ser-X-Thr/Ser. A fourth mutant was altered at two sites. The altered forms of the gIV gene were cloned into a vaccinia virus transfer vector to generate recombinant vaccinia viruses expressing mutant proteins. Analysis of these mutants revealed that only two (residues 41 and 102) of the three (residues 41, 102, and 411) potential sites for the addition of N-linked glycans are actually utilized. Absence of glycans at residue 41 (gN1) showed no significant effect on the conformation of the protein or induction of a serum neutralizing antibody response. However, mutant proteins lacking glycans at residue 102 (gN2) or residues 41 and 102 (gN1N2) showed altered reactivity with conformation-dependent gIV-specific monoclonal antibodies. These mutants also induced significantly lower serum neutralizing antibody responses than wild-type gIV. Nonetheless, each of the mutant proteins were modified by the addition of O-glycans and transported to the cell surface. Our results demonstrate that absence of N-linked glycans at one (residue 102) or both (residues 41 and 102) utilized N-linked glycosylation sites alters the conformation but does not prevent processing and transport of gIV to the cell surface.
Similar articles
-
Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses.J Virol. 1993 Apr;67(4):2103-9. doi: 10.1128/JVI.67.4.2103-2109.1993. J Virol. 1993. PMID: 8383232 Free PMC article.
-
Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein.J Gen Virol. 1995 Mar;76 ( Pt 3):705-10. doi: 10.1099/0022-1317-76-3-705. J Gen Virol. 1995. PMID: 7897359
-
Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.J Virol. 1989 Dec;63(12):5184-93. doi: 10.1128/JVI.63.12.5184-5193.1989. J Virol. 1989. PMID: 2555549 Free PMC article.
-
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.Front Immunol. 2018 Apr 27;9:910. doi: 10.3389/fimmu.2018.00910. eCollection 2018. Front Immunol. 2018. PMID: 29755477 Free PMC article. Review.
-
O-glycosylation and its role in therapeutic proteins.Biosci Rep. 2022 Oct 28;42(10):BSR20220094. doi: 10.1042/BSR20220094. Biosci Rep. 2022. PMID: 36214107 Free PMC article. Review.
Cited by
-
Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.J Virol. 1999 Dec;73(12):10214-23. doi: 10.1128/JVI.73.12.10214-10223.1999. J Virol. 1999. PMID: 10559338 Free PMC article.
-
Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses.J Virol. 1993 Apr;67(4):2103-9. doi: 10.1128/JVI.67.4.2103-2109.1993. J Virol. 1993. PMID: 8383232 Free PMC article.
-
Glycoprotein D of bovine herpesvirus 5 (BoHV-5) confers an extended host range to BoHV-1 but does not contribute to invasion of the brain.J Virol. 2010 Jun;84(11):5583-93. doi: 10.1128/JVI.00228-10. Epub 2010 Mar 10. J Virol. 2010. PMID: 20219909 Free PMC article.
-
Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus.J Virol. 2004 May;78(10):4965-75. doi: 10.1128/jvi.78.10.4965-4975.2004. J Virol. 2004. PMID: 15113876 Free PMC article.
-
Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.Clin Vaccine Immunol. 2009 Nov;16(11):1675-86. doi: 10.1128/CVI.00224-09. Epub 2009 Sep 30. Clin Vaccine Immunol. 2009. PMID: 19793901 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources